AU2001289831A1 - Medicaments against viral infections - Google Patents

Medicaments against viral infections

Info

Publication number
AU2001289831A1
AU2001289831A1 AU2001289831A AU8983101A AU2001289831A1 AU 2001289831 A1 AU2001289831 A1 AU 2001289831A1 AU 2001289831 A AU2001289831 A AU 2001289831A AU 8983101 A AU8983101 A AU 8983101A AU 2001289831 A1 AU2001289831 A1 AU 2001289831A1
Authority
AU
Australia
Prior art keywords
viral infections
against viral
medicaments against
medicaments
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289831A
Inventor
Stephan Bartel
Michael Brands
Rainer Endermann
Erwin Graef
Kerstin Henninger
Diana Koletzki
Ulrich Niewohner
Susanne Nikolic
Arnold Paessens
Karl-Heinz Schlemmer
Olaf Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000143791 external-priority patent/DE10043791A1/en
Priority claimed from DE2000154932 external-priority patent/DE10054932A1/en
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001289831A1 publication Critical patent/AU2001289831A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001289831A 2000-09-06 2001-08-24 Medicaments against viral infections Abandoned AU2001289831A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE2000143791 DE10043791A1 (en) 2000-09-06 2000-09-06 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections
DE10043791 2000-09-06
DE10054932 2000-11-06
DE2000154932 DE10054932A1 (en) 2000-11-06 2000-11-06 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections
PCT/EP2001/009772 WO2002020509A2 (en) 2000-09-06 2001-08-24 Medicaments against viral infections

Publications (1)

Publication Number Publication Date
AU2001289831A1 true AU2001289831A1 (en) 2002-03-22

Family

ID=26006936

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289831A Abandoned AU2001289831A1 (en) 2000-09-06 2001-08-24 Medicaments against viral infections

Country Status (3)

Country Link
US (1) US20020082264A1 (en)
AU (1) AU2001289831A1 (en)
WO (1) WO2002020509A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144307A (en) * 2006-04-18 2011-08-29 Abbott Lab Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
EA200900613A1 (en) * 2006-11-29 2009-10-30 Пфайзер Продактс Инк. SPIROKETONE ACETYL-COA-CARBOXYLAS INHIBITORS
PE20081559A1 (en) 2007-01-12 2008-11-20 Merck & Co Inc SPIROCHROMANONE DERIVATIVES SUBSTITUTED AS ACETYL COA CARBOXYLASE INHIBITORS
WO2008088692A2 (en) * 2007-01-12 2008-07-24 Merck & Co., Inc. Spirochromanon derivatives
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
CN102558126B (en) * 2010-12-16 2014-03-05 复旦大学 2-substituted chromone compound, as well as preparation method and application thereof
EP2670752B1 (en) 2011-02-02 2016-03-16 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
EP2675812B1 (en) 2011-02-18 2017-08-30 Vertex Pharmaceuticals Incorporated Chroman - spirocyclic piperidine amides as modulators of ion channels
CN103517910B (en) 2011-03-14 2016-12-14 沃泰克斯药物股份有限公司 Morpholine-spirocyclic piperidine amide as ion channel modulators
WO2015151001A1 (en) 2014-03-29 2015-10-08 Lupin Limited Sulfonamide compounds as voltage gated sodium channel modulators
CN104262317B (en) * 2014-09-04 2016-08-17 玉溪师范学院 A kind of dimerization monoterpenes compound and preparation method and application
CN107311973B (en) * 2017-06-25 2021-04-06 石家庄学院 Nitrate-group-containing dihydromyricetin derivative and preparation and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2611910A1 (en) * 1976-03-20 1977-09-22 Bayer Ag Substd. chroman (4) ones prodn. - by reacting (2)-hydroxy-acetophenones and ketootkk ketones in presence of sec. amines
DE2814983A1 (en) * 1978-04-07 1979-10-18 Bayer Ag NEW CHROMANON DERIVATIVES
JP3521145B2 (en) * 1993-04-09 2004-04-19 富山化学工業株式会社 Immunomodulators, cell adhesion inhibitors and therapeutic / prophylactic agents for autoimmune diseases
US5808062A (en) * 1993-11-19 1998-09-15 Warner-Lambert Company Pyrone derivatives as protease inhibitors and antiviral agents
JPH10500112A (en) * 1994-05-06 1998-01-06 ファーマコピーア，インコーポレイテッド Combination dihydrobenzopyran library
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity

Also Published As

Publication number Publication date
WO2002020509A3 (en) 2002-06-27
WO2002020509A2 (en) 2002-03-14
US20020082264A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
AU2001244188A1 (en) Medicaments against viral diseases
AU2002365120A1 (en) Medicaments
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2002223028A1 (en) Inhaler
WO2002089880A8 (en) Inhalers
AU2001236970A1 (en) Packet processor
AU2002221344A1 (en) Antiviral agents
AU2002253039A1 (en) Tramadol-based medicament
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001289831A1 (en) Medicaments against viral infections
AU2002221099A1 (en) Combination drugs
AU1645700A (en) Oenothein medicaments
AU2001232244A1 (en) Drug comprising combination
AU3533601A (en) Pacifier
AU2001248943A1 (en) Pharmaceutical curative compound
AU2001267135A1 (en) Medicaments
AU2001278360A1 (en) Wood-duroplastic composites
AU6904101A (en) Infection model
AU2002224845A1 (en) Viral expression system
AU2001292578A1 (en) Pharmaceutical compounds
AU2001266201A1 (en) Medicaments
AU2000279374A1 (en) Secure syringe
AU2001260045A1 (en) Secure pants
AU2001280820A1 (en) Telecommunication-based common contracting